FY2010 NIH awards · Principal investigators
Pediatrics at UT MD Anderson Cancer Center
Houston, TX
Funding
$7.8M
$7,767,638
Awards
19
FY2010 NIH awards in Pediatrics
Principal investigators
7
7 lead a grant here, 0 co-investigators
- NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
- These are the awards in the Pediatrics row of the UT MD Anderson Cancer Center page.
Leads a grant in this department
7 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.
Strong, Louise C
Leads 2 awards · $2,914,830
- 5P01CA034936-23Department: NIH department codeA Mutational Model for Childhood Cancer$2,854,661award amount
- 3P01CA034936-23S1Department: NIH department codeA Mutational Model for Childhood Cancer$60,169award amount
Cooper, Laurence J.n.
Leads 5 awards · $2,024,457
- 4R33CA116127-03Department: NIH department codeUCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY$899,727award amount
- 1R01CA141303-01A1Department: NIH department codeT-cell Therapy for B-lineage Acute Lymphoblastic Leukemia$303,780award amount
- 5R01CA120956-04Department: NIH department codeEnhancing the efficacy of CD19-specific cord blood-derived T Cells$292,600award amount
- 5R01CA124782-04Department: NIH department codeAdoptive immunotherapy after umbilical cord blood transplant$292,600award amount
- 1S10RR026916-01Department: NIH department codenCounter Prep Station and the Digital Analyzer$235,750award amount
Li, Shulin
Leads 4 awards · $1,130,516
- 1R01CA142855-01Department: NIH department codeIL12 Gene Therapy For Enhancing Therapeutic Efficacy of Bleomycin Against Oral Tu$327,850award amount
- 7R01CA098928-08Department: NIH department codeElimination of residual malignancy by programmed systemic cytokine gene therapy$321,460award amount
- 7R01CA120895-04Department: NIH department codeGene-Product Auto-Targeting to Tumor Vessels$300,200award amount
- 3R01CA120895-04S1Department: NIH department codeGene-Product Auto-Targeting to Tumor Vessels$181,006award amount
Kleinerman, Eugenie S
Leads 3 awards · $610,655
- 5R01CA042992-24Department: NIH department codeLiposome and Polycationic Gene Therapy for Osteosarcoma$263,918award amount
- 5R01CA103986-06Department: NIH department codeVasculogenesis in Ewing's Sarcoma: Implications for Therapy$254,023award amount
- 3R01CA042992-24S1Department: NIH department codeLiposome and Polycationic Gene Therapy for Osteosarcoma$92,714award amount
Zweidler-McKay, Patrick A
Leads 2 awards · $525,740
- 1R01CA138816-01A1Department: NIH department codeHES1 mediates cell-specific consequences of Notch signaling in ALL$319,550award amount
- 1R21CA141297-01A1Department: NIH department codeNotch in Neuroblastoma$206,190award amount
Chandra, Joya
Leads 1 award · $292,600
- 5R01CA115811-04Department: NIH department codeRole of Redox Dependent Signaling in Leukemia$292,600award amount
Hughes, Dennis Patrick Meehan
Leads 2 awards · $268,840
- 5K08CA118730-05Department: NIH department codeRas-mediated erbB signaling in Osteosarcoma$137,700award amount
- 1R01CA149501-01A1Department: NIH department codePreclinical Evaluation of ERBB Family Members as Therapeutic Targets in Osteosarc$131,140award amount